• 1145 Citations
  • 16 Scopus h-Index
20102018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sumera Rizvi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Cholangiocarcinoma Medicine & Life Sciences
Fibroblast Growth Factor Receptors Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Sclerosing Cholangitis Medicine & Life Sciences
Klatskin Tumor Medicine & Life Sciences
Bile Duct Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Biliary Tract Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2018

  • 1145 Citations
  • 16 Scopus h-Index
  • 27 Article
  • 2 Review article
  • 1 Letter
3 Citations (Scopus)

Animal models of cholangiocarcinoma

Loeuillard, E., Fischbach, S. R., Gores, G. J. & Rizvi, S., Jan 1 2018, (Accepted/In press) In : Biochimica et Biophysica Acta - Molecular Basis of Disease.

Research output: Contribution to journalArticle

Cholangiocarcinoma
Animal Models
Biliary Tract
Carcinogens
Organoids
104 Citations (Scopus)

Cholangiocarcinoma-evolving concepts and therapeutic strategies

Rizvi, S., Khan, S. A., Hallemeier, C., Kelley, R. K. & Gores, G. J., Feb 1 2018, In : Nature Reviews Clinical Oncology. 15, 2, p. 95-111 17 p.

Research output: Contribution to journalReview article

Cholangiocarcinoma
Therapeutics
Epidemiology
Exome
Precision Medicine
6 Citations (Scopus)

Emerging Technologies for the Diagnosis of Perihilar Cholangiocarcinoma

Rizvi, S., Eaton, J., Yang, J. D., Chandrasekhara, V. & Gores, G. J., May 1 2018, In : Seminars in Liver Disease. 38, 2, p. 160-169 10 p.

Research output: Contribution to journalArticle

Klatskin Tumor
Technology
Cell Biology
Pathologic Constriction
Sclerosing Cholangitis

Fibroblast Growth Factor Receptor Inhibition for Cholangiocarcinoma: Looking Through a Door Half-Opened

Rizvi, S. & Gores, G. J., Jan 1 2018, (Accepted/In press) In : Hepatology.

Research output: Contribution to journalArticle

Fibroblast Growth Factor Receptors
Cholangiocarcinoma
3 Citations (Scopus)

Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma

Kabashima, A., Hirsova, P., Bronk, S. F., Hernandez, M. C., Truty, M., Rizvi, S., Kaufmann, S. H. & Gores, G. J., Jan 1 2018, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

Fibroblast Growth Factor Receptors
Myeloid Leukemia
Cholangiocarcinoma
Myeloid Cells
Necrosis